Trademark: 97541170
Word
ETRUSVYQUE
Status
Registered
Status Code
700
Status Date
Tuesday, July 9, 2024
Serial Number
97541170
Registration Number
7436209
Registration Date
Tuesday, July 9, 2024
Mark Type
4
Filing Date
Tuesday, August 9, 2022
Published for Opposition
Tuesday, April 23, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
May 26, 2023
Assigned To Examiner
Aug 12, 2022
New Application Entered
Aug 29, 2022
New Application Office Supplied Data Entered
May 30, 2023
Suspension Letter Written
May 30, 2023
Letter Of Suspension E-Mailed
May 30, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 12, 2023
Teas Change Of Owner Address Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Correspondence Received
Sep 25, 2023
Teas Response To Suspension Inquiry Received
Jan 10, 2024
Suspension Checked - To Attorney For Action
Mar 15, 2024
Correspondence Received In Law Office
Mar 15, 2024
Teas/Email Correspondence Entered
Mar 18, 2024
Suspension Checked - To Attorney For Action
Mar 18, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2024
Registered-Principal Register
Jul 9, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24